Management of Diabetic Dyslipidemia: Need for Reappraisal of the Goals

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.5, Iss.2, 2005-01, pp. : 83-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosuvastatin: A Review of its Use in the Management of Dyslipidemia

By Scott Lesley J. Curran Monique P. Figgitt David P.

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. : 117-138

Adis International

Access to resources Recommend Favorite

The Effects of Medications Used for the Management of Dyslipidemia on Postprandial Lipemia

Current Medicinal Chemistry, Vol. 16, Iss. 2, 2009-01 ,pp. : 203-217

Bentham Science Publishers

Access to resources Recommend Favorite

Traditional Risk Factors for Coronary Atherosclerosis in Indo Asians: The Need for a Reappraisal

Current Pharmaceutical Design, Vol. 12, Iss. 13, 2006-05 ,pp. : 1611-1621

Bentham Science Publishers

Access to resources Recommend Favorite

Urapidil: A Reappraisal of its Use in the Management of Hypertension

By Dooley M. Goa K.L.

Drugs, Vol. 56, Iss. 5, 1998-11 ,pp. : 929-955

Adis International

Access to resources Recommend Favorite

Diabetic Gastroparesis: Diagnosis and Management

By Jing Rayner Christopher K. Jones Karen L. Horowitz Michael

Drugs, Vol. 69, Iss. 8, 2009-06 ,pp. : 971-986

Adis International

Access to resources Recommend Favorite